NAGE FY 2021 Earnings — Niagen Bioscience Inc Revenue & Financial Results | Market Cap Arena

NAGENiagen Bioscience Inc

$423M

FY 2021 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$67M+13.8% YoY

Gross Profit

$41M61.5% margin

Operating Income

-$27M-40.1% margin

Net Income

-$27M-40.2% margin

EPS (Diluted)

$-0.40

Cash Flow

Operating Cash Flow

-$24M

Free Cash Flow

-$25M

Stock-Based Comp.

$6M

Balance Sheet

Total Assets

$58M

Total Liabilities

$26M

Stockholders' Equity

$32M

Cash & Equivalents

$28M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$67M	$59M	+13.8%
Gross Profit	$41M	$35M	+17.6%
Operating Income	-$27M	-$20M	-36.4%
Net Income	-$27M	-$20M	-36.2%